Cargando…
GBA1 Gene Mutations in α-Synucleinopathies—Molecular Mechanisms Underlying Pathology and Their Clinical Significance
α-Synucleinopathies comprise a group of neurodegenerative diseases characterized by altered accumulation of a protein called α-synuclein inside neurons and glial cells. This aggregation leads to the formation of intraneuronal inclusions, Lewy bodies, that constitute the hallmark of α-synuclein patho...
Autores principales: | Granek, Zuzanna, Barczuk, Julia, Siwecka, Natalia, Rozpędek-Kamińska, Wioletta, Kucharska, Ewa, Majsterek, Ireneusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917178/ https://www.ncbi.nlm.nih.gov/pubmed/36768367 http://dx.doi.org/10.3390/ijms24032044 |
Ejemplares similares
-
Targeting NLRP3-Mediated Neuroinflammation in Alzheimer’s Disease Treatment
por: Barczuk, Julia, et al.
Publicado: (2022) -
Inhibition of Protein Aggregation and Endoplasmic Reticulum Stress as a Targeted Therapy for α-Synucleinopathy
por: Siwecka, Natalia, et al.
Publicado: (2023) -
IRE1α Inhibitors as a Promising Therapeutic Strategy in Blood Malignancies
por: Wiese, Wojciech, et al.
Publicado: (2022) -
PI3K/Akt/mTOR Signaling Pathway in Blood Malignancies—New Therapeutic Possibilities
por: Wiese, Wojciech, et al.
Publicado: (2023) -
The Potential Role of Small-Molecule PERK Inhibitor LDN-0060609 in Primary Open-Angle Glaucoma Treatment
por: Rozpędek-Kamińska, Wioletta, et al.
Publicado: (2021)